X-linked adrenoleukodystrophy;Adrénoleucodystrophie liée à l'X

Annales d'Endocrinologie

Volumn 68, Issue 6, 2007, Pages 403-411

  Aubourg, P ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

ABC transporter; Adrenoleukodystrophy; Adrenomyeloneuropathy; Bone marrow transplantation; Gene therapy; Hematopoietic stem cell; Leukodystrophy; Peroxisome; X linked

Indexed keywords

FLUDROCORTISONE; HYDROCORTISONE; PROTEIN; PROTEIN ABCD1; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADRENOLEUKODYSTROPHY; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; FALSE NEGATIVE RESULT; GENE MUTATION; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; HEMIZYGOTE; HETEROZYGOTE; HUMAN; INCIDENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRENATAL DIAGNOSIS; SHORT SURVEY; X CHROMOSOME LINKED DISORDER;

ADRENOLEUKODYSTROPHY; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MALE; PHENOTYPE;

EID: 36549044343     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2007.04.002     Document Type: Short Survey

References (43)

1. Asheuer M., Pflumio F., Benhamida S., et al. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc. Natl. Acad. Sci. USA 101 (2004) 3557-3562
2. Assies J., Gooren L.J., Van Geel B., and Barth P.G. Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study. Int. J. Androl. 20 (1997) 315-321
3. Aubourg P., Blanche S., Jambaqué I., et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N. Engl. J. Med. 322 (1990) 1860-1866
4. Aubourg P., and Chaussain J.L. Adrenoleukodystrophy presenting as Addison's disease in children and adults. Trends Endocrinol. Metab. 2 (1991) 49-52
5. Aubourg P., Adamsbaum C., Lavallard-Rousseau F., et al. A two-year trial of oleic ans erucic acids (Lorenzo' oil) as treatment for adrenomyeloneuropathy. N. Engl. J. Med. 329 (1993) 745-753
6. Aubourg P. X-linked adrenoleukodystrophy. In: Vinken P.J., Bruyn G.W., and Moser H.W. (Eds). Hanbook of Clinical Neurology (1996), Dds. Elsevier, Amsterdam 447-483
7. Aubourg P., and Dubois-Dalcq M. The X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia?. Glia 29 (2000) 186-190
8. Benhamida S., Pflumio F., Dubart-Kupperschmitt A., et al. Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice. Mol. Ther. 7 (2003) 317-324
9. Berger J., and Gartner J. X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects. Biochim. Biophys. Acta 1763 (2006) 1721-1732
10. Bergthorsdottir R., Leonsson-Zachrisson M., Oden A., and Johannsson G. Premature Mortality in Patients with Addison's Disease: A Population-Based Study. J. Clin. Endocrinol. Metab. 91 (2006) 4849-4853
11. Bezman L., Moser A.B., Raymond G.V., et al. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann. Neurol. 49 (2001) 512-517
12. Cartier N. Gene therapy strategies for X-linked adrenoleukodystrophy. Curr. Opin. Mol. Ther. 3 (2001) 357-361
13. el-Deiry S.S., Naidu S., Blevins L.S., and Ladenson P.W. Assessment of adrenal function in women heterozygous for adrenoleukodystrophy. J. Clin. Endocrinol. Metab. 82 (1997) 856-860
14. Dubey P., Fatemi A., Barker P.B., et al. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy. Neurology 64 (2005) 304-310
15. Dubey P., Fatemi A., Huang H., et al. Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Ann. Neurol. 58 (2005) 758-766
16. Dubois-Dalcq M., Feigenbaum V., and Aubourg P. The neurobiology of X-linked adrenoleukodystrophy (ALD), a demyelinating peroxisomal disorder. Trends Neurosci. 22 (1999) 4-12
17. Eichler F.S., Barker P.B., Cox C., et al. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology 58 (2002) 901-907
18. Eichler F.S., Ito R., Barker P.B., et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 225 (2002) 245-252
19. Fatemi A., Barker P.B., Ulug A.M., et al. MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy. Neurology 60 (2003) 1301-1307
20. Fatemi A., Smith S.A., Dubey P., et al. Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy. Neurology 64 (2005) 1739-1745
21. Hudspeth M.P., and Raymond G.V. Immunopathogenesis of adrenoleukodystrophy: Current understanding. J. Neuroimmunol (2006) [Epub ahead of print]
22. Kemp S., and Wanders R.J. X-linked adrenoleukodystrophy: Very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol. Genet. Metab. 90 (2007) 268-276
23. Kemp S., Valianpour F., Denis S., et al. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol. Genet. Metab. 84 (2005) 144-151
24. Kumar A.J., Rosenbaum A.E., Naidu S., et al. Adrenoleukodystrophy: correlating MR imaging with CT. Radiology 165 (1987) 497-504
25. Kumar A.J., Köhler W., Kruse B., et al. MR findings in adult-onset adrenomyeloleukodystrophy. AJNR Am. J. Neuroradiol. 16 (1995) 1227-1237
26. Laurenti S., Aubourg P., Calcinaro F., et al. Etiologic diagnosis of primary adrenal insufficiency using an original flow-chart of immune and biochemical marker. J. Clin. Endocrinol. Metab. 83 (1998) 3163-3168
27. Loes D.J., Fatemi A., Melhem E.R., et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 61 (2003) 369-374
28. Maestri N.E., and Beaty T.H. Predictions of a 2-locus model for disease heterogeneity: application to adrenoleukodystrophy. Am. J. Med. Genet. 44 (1992) 576-582
29. Mosser J., Douar A.M., Sarde C.O., et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361 (1993) 726-730
30. Moser H.W., Smith K.D., Watkins P.A., Powers J., and Moser A.B. X-linked adrenoleukodystrophy. In: Scriver C.R., and Beaudet A.L. (Eds). The Metabolic and Molecular Bases of Inherited Diseases, 8th Ed (2001), Mcgraw-Hill, New York 3257-3301
31. Moser H.W., Raymond G.V., Lu S.E., et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. Arch. Neurol. 62 (2005) 1073-1080
32. Peters C., Charnasi L.R., Tan Y., et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104 (2004) 881-888
33. Pujol A., Hindelang C., Callizot N., Bartsch U., Schachner M., and Mandel J.L. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum. Mol. Genet. 11 (2002) 499-505
34. Pujol A., Ferrer I., Camps C., et al. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet. 13 (2004) 2997-3006
35. Restuccia D., Di Lazzaro V., Valeriani M., et al. Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy. Neurology 52 (1999) 810-816
36. Restuccia D., DI Lazzaro V., Valeriani M., et al. Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement. Brain 120 (1997) 1139-1148
37. Rizzo W.B., Leshner R.T., Odone A., et al. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology 39 (1989) 1415-1422
38. Shapiro E., Krivit W., Lockman L., et al. Long-term beneficial effect of bone marrow transplantation for childhood onset cerebral X-linked adrenoleukodystrophy. Lancet 356 (2000) 713-718
39. Uziel G., Bertini E., Bardelli P., Rimoldi M., and Gambetti M. Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy. Dev. Neurosci. 13 (1991) 274-279
40. Van Geel B.M., Bezman L., Loes D.J., Moser H.W., and Raymond G.V. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann. Neurol. 49 (2001) 186-194
41. Weinhofer I., Forss-Petter S., Kunze M., Zigman M., and Berger J. X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism. FEBS Lett. 579 (2005) 5512-5516
42. Wilken B., Dechent P., Brockmann, et al. Quantitative proton magnetic resonance spectroscopy of children with adrenoleukodystrophy before and after hematopoietic stem cell transplantation. Neuropediatrics 34 (2003) 237-246
43. X-linked Adrenoleukodystrophy Database. http://www.x-ald.nl/.